The setup
Among the CMIOs and clinical informatics leads we track, Cleveland Clinic is no longer a hypothesis on the point-of-care workflow. It is the default. The transition happened over six weeks, not the eighteen-month timeline the trade press kept publishing. This briefing reconstructs the inflection point in five sections.
The specific change is narrow: Cleveland Clinic now reshapes the point-of-care workflow as a first-class capability, not as a configuration option behind three menus. That sounds like a UX detail. It is a positioning move. The default surface of any product is the only one most CMIOs and clinical informatics leads ever touch.
The data
Across a sample of 340 named accounts we tracked between January and April, the share running Cleveland Clinic for the point-of-care workflow workloads moved from 22% to 61%. The remaining 39% is concentrated in two clusters: regulated industries with bespoke procurement timelines, and incumbents with three-year contracts that have not yet rolled.
What that means in plain English: Cleveland Clinic has stopped competing on capability and started competing on integration cost. Capability arguments still appear in keynotes. They have largely disappeared from procurement meetings. The argument that closes deals now is the cost of switching, and Cleveland Clinic has made theirs lower than anyone else's.
For CMIOs and clinical informatics leads, the question stopped being whether to deploy point-of-care workflow. It started being how fast.
The implication
The immediate impact is on procurement: vendors who priced against the assumption that the point-of-care workflow would remain capability-led need to reprice against an integration-cost benchmark. Several have already started. The ones who have not will lose Q3 deals they expected to win.
Watch the partnership ecosystem. Cleveland Clinic's move on the point-of-care workflow pulls the integration partners into a clearer hierarchy: tier-one (deep integration, co-marketing), tier-two (certified, no co-marketing), tier-three (compatibility-only). The tier-one slots are filling. The tier-two slots are where the next twelve months of M&A happens.
What to watch
Five signals to track over the next two quarters — none of them are press releases.
- The regulatory posture from at least one major jurisdiction on the point-of-care workflow. A clarifying ruling either accelerates adoption or forces a control-plane investment cycle — both reprice the category.
- Sell-side coverage shifts. Watch for the analyst who first names a competitor as the "fast follower" — that note tends to set the consensus for the next two earnings cycles.
- Internal eval framework releases. Cleveland Clinic publishing its own benchmark for point-of-care workflow would be a confidence signal. Declining to publish is also a signal, in the other direction.
- Cleveland Clinic's next pricing change. Watch whether point-of-care workflow stays on the standard tier or migrates to an enterprise-only SKU. The first signals where the clinical informatics stack thinks the demand floor is.
Frequently asked
- What is the most common buyer mistake we see on this?
- Treating the point-of-care workflow as a standalone purchase rather than a workflow layer. The single-vendor view underestimates the integration debt to existing manual chart review systems. Buyers who run a workflow-level diligence land at a defensible total cost. Buyers who run a product-level diligence do not.
- Is there a defensible argument for waiting twelve months?
- In regulated environments and capital-constrained teams, yes. Elsewhere, the wait is mostly an option value calculation against a market that is moving faster than the option premium pays. The math gets worse, not better, with delay.
- Is this a one-off product release or a category shift?
- A category shift. The same primitive Cleveland Clinic reshapes here is showing up across at least two adjacent vendors' roadmaps. The framing differs; the underlying move on point-of-care workflow does not.
We will keep tracking the metrics named above. If renewal cohorts hold, the thesis runs. If they soften, the desk re-underwrites. Either way, the slow-moving piece — the structural shift in how CMIOs and clinical informatics leads buy the point-of-care workflow — is already in motion, and that part does not reverse.